This website uses cookies to help us give you the best experience on our website. To learn more about how we use cookies, please see our Privacy Policy. To accept cookies from this site, please click the button to the right. OK This website uses cookies to help us give you the best experience on our website. To learn more about how we use cookies, please see our Privacy Policy. To accept cookies from this site, please click the button to the right. OK Developing Novel Tests for the Early Detection of Cancer Abcodia is dedicated to transforming clinical care through the earlier detection of cancer. We focus on measuring and modeling dynamic changes in serum-based biomarkers over time. Our first product, the ROCA Test, is a blood test for the early detection of ovarian cancer. OUR APPROACH Products and Services The ROCA Test The ROCA® Test is a simple blood test that helps determine a woman's risk of having ovarian cancer. LEARN MORE Serum Biobank Abcodia has exclusive commercial rights to a serum biobank that allows discovery and validation of biomarkers of early disease formation. LEARN MORE About Us Abcodia is a clinical stage company engaged in the commercial development of novel, validated tests for the early detection of cancer. The Company’s first product is the ROCA Test for the early detection of ovarian cancer, and it is also expanding its pipeline of early detection technologies for lung, colorectal and pancreatic cancer. Abcodia’s offerings are based on expertise in measuring and modeling dynamic changes over time of serum-based biomarkers before cancer is clinically diagnosed. To support this work, the Company maintains exclusive commercial access to a biobank of 5 million serum samples donated from 200,000 individuals over a 10-year period and works in partnership to evaluate potential new markers. READ MORE Helpful Links About Abcodia The ROCA Test Biobank Contact Us © Copyright 2021 Abcodia Ltd. All Rights Reserved. Site Map Legal & Privacy Policies  